Literature DB >> 27302222

Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?

Giovanni B Frisoni1, Oskar Hansson2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27302222     DOI: 10.1016/S1474-4422(16)30040-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  1 in total

1.  β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease.

Authors:  Atul Kumar; Shorena Janelidze; Erik Stomrud; Sebastian Palmqvist; Oskar Hansson; Niklas Mattsson-Carlgren
Journal:  Neurology       Date:  2022-05-31       Impact factor: 11.800

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.